Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.

2.

Study confirms link between breast density, higher breast cancer risk

3.

More pain, more gain? New biopsy technique found to improve prostate cancer detection

4.

Year in Review: Chronic Lymphocytic Leukemia

5.

New Gene Therapy Nears EU Nod for Bladder Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot